Medicare Drug Plan Costs to Rise 50% in 2027, Experts Warn
Medicare prescription drug premiums are set to surge 50% in 2027, making open enrollment decisions critical for beneficiaries.
Medicare prescription drug plan costs are projected to jump 50% in 2027, a sharp increase that financial advisers and health policy experts say makes active participation in open enrollment more important than ever for beneficiaries.
The looming premium surge puts a spotlight on the annual open enrollment window, during which Medicare recipients can review, switch, or update their Part D prescription drug coverage. Failing to reassess a plan during this period could leave enrollees locked into coverage that costs significantly more next year than they currently pay.
Read more Free Retirement Lunch Seminars Often Mask Annuity Sales Pitches →
While the source of the increase was not broken down in granular detail, the magnitude of the projected rise reflects ongoing pressures in the Medicare drug coverage market, including changes stemming from recent federal legislation that restructured how out-of-pocket drug costs are calculated and shifted more financial responsibility to insurance plans.
Financial planners widely caution that many beneficiaries make the mistake of allowing their existing coverage to auto-renew without comparing available alternatives. Even a modest amount of time spent during open enrollment reviewing competing plans can translate into hundreds of dollars in annual savings, particularly as premium baselines reset heading into 2027.
Medicare open enrollment typically runs from October 15 through December 7 each year, giving beneficiaries roughly seven weeks to evaluate their options before coverage changes take effect on January 1. Continue reading at MarketWatch.com
